ArticleTranslational lung cancer research2022
An exploration of the clinical progression models of osimertinib in the treatment of advanced EGFR-mutant non-small cell lung cancer.
Yue Shi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.